Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary Cutaneous DLBCL Leg-type

Hemasphere. 2022 Mar 1;6(3):e690. doi: 10.1097/HS9.0000000000000690. eCollection 2022 Mar.

Christopher S Trethewey^{1

2}, Harriet S Walter^{1

2

3}, Abdullah N M Alqahtani^{1

2}, Ralf Schmid^{4

5}, David S Guttery², Yvette Griffin³, Matthew J Ahearne^{1

2

3}, Gerald S Saldanha^{2

3}, Sandrine P N Jayne^{1

2}, Martin J S Dyer^{1

2

3}

¹ Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom.
² Leicester Cancer Research Centre, University of Leicester, United Kingdom.
³ University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
⁴ Department of Molecular and Cell Biology, University of Leicester, United Kingdom.
⁵ Leicester Institute of Structural and Chemical Biology, University of Leicester, United Kingdom.

No abstract available

Publication types